共 253 条
[1]
Teoh Z(2020)COURAGE, ORBITA, and ISCHEMIA: Percutaneous Coronary Intervention for Stable Coronary Artery Disease Interv Cardiol Clin 9 469-82
[2]
Al-Lamee RK(2019)2018 ESC/EACTS Guidelines on myocardial revascularization Eur Heart J 40 87-165
[3]
Neumann FJ(2013)Patient preferences for coronary artery bypass graft surgery or percutaneous intervention in multivessel coronary artery disease Catheter Cardiovasc Interv 82 212-8
[4]
Sousa-Uva M(2018)Patients’ preferences for coronary bypass grafting or staged percutaneous coronary intervention in multi-vessel coronary artery disease Int J Clin Pract 72 e13056-407
[5]
Ahlsson A(2020)Initial Invasive or Conservative Strategy for Stable Coronary Disease N Engl J Med 382 1395-16
[6]
Alfonso F(2007)Optimal medical therapy with or without PCI for stable coronary disease N Engl J Med 356 1503-57
[7]
Banning AP(2021)Cost-effectiveness analysis of percutaneous coronary intervention for single-vessel coronary artery disease: an economic evaluation of the ORBITA trial BMJ Open 11 e044054-31
[8]
Benedetto U(2014)Cost-effectiveness of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with 3-vessel or left main coronary artery disease: final results from the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) trial Circulation 130 1146-8
[9]
Byrne RA(2013)Cost-effectiveness of percutaneous coronary intervention with drug eluting stents versus bypass surgery for patients with diabetes mellitus and multivessel coronary artery disease: results from the FREEDOM trial Circulation 127 820-8
[10]
Collet JP(2015)Cost-effectiveness of percutaneous coronary intervention versus bypass surgery from a Dutch perspective Heart 101 1980-38